Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma

Clinical trial NCT03035630 · WITHDRAWN

Trial details

NCT number: NCT03035630
Sponsor: Guru Sonpavde
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Clear-cell Renal Cell Carcinoma RCC Kidney Cancer Clear-cell Kidney Carcinoma

Start date: 2017-05-23
Primary completion: 2018-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.